Kevin L. Carter

Rapid Whole-Genome Sequencing in a Neonatal MRSA Outbreak

08/16/2012

Although rapid whole-genome sequencing has been successfully used as a research tool with discriminatory power in outbreaks, it is also potentially useful for its possible clinical utility in a diagnostic setting. A compelling target is...

Although rapid whole-genome...

08/16/2012

First Report Managed Care

Conference Insider

Federal and State Legislative Update

05/17/2013

Kevin L. Carter ;

San Diego—The federal budget sequester struggle, the continuing movement toward the implementation of the Patient Protection and Affordable Care Act (ACA), and issues facing Medicare Part D are among the most significant legislative and...

San Diego—The federal budget...

05/17/2013

First Report Managed Care

Comparative Effectiveness Research by States

05/24/2012

Kevin L. Carter ;

San Francisco—Jenny Gaffney, a senior manager with Avalere Health in Washington, said at the AMCP meeting that over the past few years comparative effectiveness research (CER) has been utilized increasingly by states looking to improve the...

San Francisco—Jenny Gaffney, a...

05/24/2012

First Report Managed Care

News Connection

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

10/23/2013

Kevin L. Carter ;

Vedolizumab, a humanized monoclonal antibody, selectively blocks gut lymphocyte trafficking without interfering with trafficking to the central nervous system.

Vedolizumab, a humanized...

10/23/2013

First Report Managed Care

Biomarker Changes in Alzheimer Disease

12/17/2012

Kevin L. Carter ;

Alzheimer disease (AD) is the most common cause of dementia and currently affects about 5 million Americans. By 2050, this number is expected to increase to 13 million.

Alzheimer disease (AD) is the...

12/17/2012

First Report Managed Care

Department

Adult Vaccination Strategies for Invasive Pneumococcal Disease

06/19/2012

Kevin L. Carter ;

Although the 23-valent pneumococcal polysaccharide vaccine (PPSV23) has been recommended for prevention of invasive pneumococcal disease (IPD) in adults since 1983, there have been no conclusive assessments of its ability to prevent...

Although the 23-valent...

06/19/2012

First Report Managed Care

Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer

08/16/2012

Kevin L. Carter ;

The administration of radioiodine (131I) has traditionally been part of therapy to patients with thyroid cancer after thyroidectomy; however, it is unclear whether this administration provides any benefit after a complete surgical resection....

The administration of...

08/16/2012

First Report Managed Care

Conference Insider

Evaluating a Program to Reduce MRSA Infections after Cardiothoracic Surgery

03/21/2011

Kevin L. Carter ;

Although the incidence of surgical site infections (SSIs) after cardiothoracic (CT) surgery is relatively low, these infections can carry significant morbidity and mortality and can incur substantial costs. The overall incidence of serious...

Although the incidence of...

03/21/2011

First Report Managed Care

Development of Electronic Prior Authorization Has Reached an Inflection Point

05/24/2012

Kevin L. Carter ;

San Francisco—“With the possibility of radical changes in the way pharmacy benefits are administered and delivered, the development of electronic prior authorization (ePA) has reached an inflection point, and the industry needs to work...

San Francisco—“With the...

05/24/2012

First Report Managed Care

Targeted Therapies for Cancer

11/21/2013

Kevin L. Carter ;

The treatment of cancer is evolving from a largely reactive, empirical approach to a proactive one in which genomic information is used to improve diagnostic accuracy, guide therapeutic choices, and improve patient outcomes.

The treatment of cancer is...

11/21/2013

First Report Managed Care